FDA’s New Guidance Plan to Face Trump’s Transparency Efforts

A revamped plan to streamline the FDA’s guidance practices stands to be tested as President-elect Donald Trump looks to follow through on plans to bring more transparency and efficiency to the government.

The Food and Drug Administration published in December its plan outlining new approaches to how it will issue and implement an increasing number of guidance documents that describe the agency’s interpretation of regulations and policies.

Trump has said his picks to lead major health agencies will restore “the traditions of Gold Standard Scientific Research, and beacons of Transparency,” in particular through Robert F. Kennedy Jr., as health secretary ...